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It is generally accepted that  acquired resistance  against  intracellular bac- 
terial parasites rests with the macrophage. A series of investigations from this 
laboratory has  shown  that  the  specific immune  mechanism  which  leads  to 
activation  of  macrophages,  and  consequent  immunity,  is  mediated  by  cells 
belonging  to  the  lymphoid series  (1,  2).  The passive  transfer of  specifically 
immune lymphoid cells to normal recipients was shown to confer immediate 
protection  against  challenge  with  Listeria  monocytogenes.  Obviously,  some 
mechanism must exist for an interaction between the donor lymphoid cells and 
the host macrophages. 
Although  the  nature  of  the  underlying  mechanism  in  acquired  cellular 
resistance is still obscure, the adoptively immunized animal lends itself to an 
illuminating extension of the observations reported in a  companion paper (3). 
Here it was shown that the administration of various cytotoxic drugs effectively 
suppresses  the  development of  acquired resistance in  Listeria-infected  mice. 
But it could not be  concluded unequivocally that  the  effects observed were 
always due to interference with the host's immune response, because the drugs 
examined have broadly cytotoxic properties,  and  were used  in  high  dosage. 
This uncertainty was overcome in  the present report by using passively im- 
munized  animals  to  distinguish  between  specific  interference with  the  im- 
munological  components  of  the host's  cellular defenses and  spurious  effects 
which do not result from immunosuppression in its accepted sense. 
Materials and Methods 
M/ce.--Female specific  pathogen-free (SPF) mice, aged 5-7 wk and weighing between 18 
and 22 g, were used. 
Organis~n~.--Listeria monocytogene.s, strain  EGD,  was used. This strain has been main- 
tained by alternate passage in the mouse  spleen and trypticase soy broth (TSB) medium, and 
has a I~Us0 of approximately  5 X 10' viable L/ster/~. 
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lnfection.--Mice were infected with a logarithmic phase culture of L. monocytogenes in TSB 
medium, appropriatedly diluted with H~tnks' balanced salt solution to contain the desired 
number of bacteria in 0.2 ml of the inoculum.  Inocula of between los -- 5 X  los viable 
Liateria were used for immunization of prospective donors.  The dose used to challenge pas- 
sively immunized recipients varied between 104 and los. 
Preparation and Transfer of Cell Suspensions.--The procedure for preparing spleen cell sus- 
pensions has been described in detail elsewhere  (1).  The donor mice were killed on day 7 of 
the immunizing  infection and were used to prepare filtered spleen cell suspensions which were 
injected intravenously  into recipients in a dose of approximately 2 X  l0  s cells (viability 80 -- 
90%) in a volume of 0.5 ml.  The general design consisted of injecting 10 recipients for each 
experimental group under study. 
Drugs.--AZT* (Imuran, generously supplied by Burroughs Wellcome & Co.,  Tuckahoe, 
N. Y.). MTX  x (Lederie Laboratories, Divisionof  AmeticanCyanamid Co., Pearl River, N. Y.) 
and  CY  a  (Cytoxan,  Mead  Johnson  &  Co.,  Evansville, Ind.)  were  injected as aqueous 
solutions subcutaneously in doses of 200, 50, and 200 mg/kg body-weight, respectively. VLB  x 
(vinealeucoblastine  sulfate, Velban, Eli Lilly  and Co., Indianapolis, Ind.) was administered in- 
travenously in a dose of 4 mg/kg. All drugs were given as single dose treatments, adminis- 
tered on the day specified. These dosages have been shown to be effective in suppressing the 
primary immune response to Listeria infection in mice (3). 
Irradiation.--In the experiments involving  irradiation, groups of prospective recipient mice 
were irradiated with 900 fads X-irradiation 24 hr prior to passive immunization  with immune 
lymphoid cells. 
Measurement of Protective Immunity.--Mice were challenged with an intravenous injection 
of approximately los viable Listeria immediatdy after cell transfer. In each challenge experi- 
ment, 15 normal mice were included as controls; five of these were sacrificed at 10 rain after in- 
fection in order to establish the bacterial content in the liver and the spleen at the start of 
infection; thereafter, bacterial counts were made on five mice from each group at 24 and 48 hr. 
The viable counts were determined by plating appropriate dilutions of homogenates of liver 
and spleen on TSA medium and incubating the plates overnight at 37°C. 
RESULTS 
Protective  Immunity in Passively Immunized Mice.-- 
A pre|~m~nary study was undertaken to assess the degree  of protection provided by the 
passive transfer of immune lymphoid cells to normal recipients. The course of challenge in- 
fecfion was studied in three groups of mice: (a) the immune donors challenged on the day of 
transfer; (b) a group of passively immunized mice which received immune lymphoid cells from 
7-day ~mmune donors; and (c) normal controls. The results are presented in Fig. 1. 
Listeria multiplied in the  livers and spleens of  the  control mice during the 
first 48 hr of infection. In contrast,  the  actively immunized donor mice were 
highly resistant  to  the  challenge infection; a  progressive fall occurred  in the 
viable  count  during  48  hr.  Animals which  received  immune  lymphoid  cells 
showed a  substantial degree of protection which was more rapidly established 
in the spleen than in the liver. 
Protective Immunity in Mice Treated with a Single Dose of Drug on the Day of 
Passive Immunization.-- 
Three groups of mice were used to study the effect of cyciophosphamide on the passive 
transfer of immunity: (a)  a group of passively immunized mice treated with a single dose of 
a AZT,  azathioprine;  MTX,  methotrexate;  CY,  cyciophosphamide;  VLB,  vinblastine. S.  P.  TRIPATIIY  AND  G.  ]3.  ~F~ACKANESS  19 
cyclophosphamide at the time of cell transfer; (b) a group of passively ;mmunized controls; 
and  (c)  a  group of unimmunized controls. The course of infection was followed for 48 hr. 
The  results,  presented  in  Fig.  2,  showed  that  Listeria  underwent  rapid 
multiplication in control mice during 48 hr. Passively immunized mice showed 
considerable immunity, as indicated by the lower viable counts in spleens and 
livers at 24  and 48 hr.  The Listeria counts in the cyclophosphamide-treated 
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Fro.  1.  Growth curves of L. monocytogene, s in 7-day immune  donors,  the recipients of 2  X 
108 immune lymphoid cells, and in normal controls.  Means of 5. 
recipients of immune cells were considerably higher than in the corresponding 
untreated animals, indicating the suppression of passive transfer of immunity 
by cyclophosphamide. 
Experiments of similar design were used to study the effects of vinblastine, 
methotrexate, and azathioprine. The results are presented in Figs. 3-5. In each 
of the experiments, passively immunized mice exhibited immunity to Listeria 
challenge which was evident at 24 and at 48 hr in the spleen, but usually only 
at 48 hr in the liver (1). 
Vinblastine  administered  to  passively immunized mice  at  the  time of in- 2 
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Fro. 2.  Growth curves of L. ~o~wcy~gene,  s in normal controls and two groups of recipients 
of immune spleen cells to one of which cyclophosphamide (CY) was ~rn;,i~tered at the time 
of cell transfer. 
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F~o.  3.  Growth curves of L. ~onocy/ogc~s  in normal controls and two groups of recipients 
of ~rnmune spleen cells to one of which vinblastine  (VLB)  was administered  at the time of cell 
transfer. 
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fection effectively suppressed the passive transfer of immunity (Fig. 3). Metho- 
trexate, on the other hand, had only a  slight effect (Fig 4), while azathioprine 
had no effect at all (Fig. 5). 
Effect of Treatment of Redpients with Single Doses of Drugs a Day Prior to 
Passive Immunizatlon.--In the preceding section, treatment of recipients with 
eyclophosphamide  or  vinblastine  at  the  time  of  cell  transfer  was  found  to 
7 
a6 
o 
5 
o 
~4 
0 
8  LIVER  • 
Contro[J  7 
/  c.,, ÷ ./* 
4 
I  I  2 
SPLEEN ~e 
Control 
e-- 
I  I 
24  48  24  48 
hr  hr 
FIO. 4.  Growth curves of L. monocytogenea  in normal controls and two groups of recipients 
of immune spleen cells to one of which methotrexate (MTX) was administered at the time of 
cell transfer. 
suppress passive ;mmunization. It was not dear, however, whether the ;mmuno- 
suppressive activity was the result of a  cytotoxic action on the transferred im- 
mune lymphoid cells or on recipient cells which may also be required for the 
expression of passive immunity. 
To elucidate this problem, prospective recipients were  treated with single injections of 
cyclophosphamide or vinblastine 24 hr before the scheduled time of cell transfer; the course of 
Listeria infection in these mice, when challenged at the time of cell transfer, was studied in 
relation to the growth curves in control mice and in passively imm,nized mice which had re- 
ceived no drug. The results are presented in Fig. 6 for cyclophosphamide,  and in Fig. 7 for 
vinblastine. o 
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FIG. 5.  Growth curves of L. monocytogenes in normal controls and two groups of recipients 
of immune spleen cells to one of which azathioprine  (AZT) was administered at the time of 
cell transfer. 
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FIG.  6.  Growth curves of L. monocytogenes in: normal mice (control); recipients of immune 
cells from cyclophosphamide-treated donors (CY-ceUs); recipients of immune cells from  un- 
treated immune donors (cells) ; and recipients which had been treated with cyclophosphamide 
24 hr prior to transfer of immune spleen ceils (ceils -}- CY T_~,). 
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Prior treatment of recipients with cyclophospb~mide or vinblastine failed to 
prevent the transfer of immunity by immune lymphoid cells; this suggests that 
immunosuppression resulting from the administration of these drugs to recip- 
ients at the time of cell transfer is due to their action on the transferred cells. 
Effect of Treatment of Donors with Single Doses o/Drugs a Day Prior to liar- 
resting of cells.-- 
The effect of cyclophosphamide  on the immunologically  committed cells of the donors was 
studied by treating half of a group of imm~miT¢d  mice with a single injection of cyclophospha- 
o 
.'5 
-s 
o  m 
o  ~  _1 
LIVER 
Control 
I  I 
24  48 
hr 
7  SPLEEN 
5 
/  VLB-celIs 
3  ~  "Cells 
2  ,I  I 
24  48 
hr 
FIG. 7.  Growth curves of L. monocytog~ea in normal mice (control), in recipients of spleen 
cells from immune donors (cells), and immune donors which had been treated with vinblastine 
24 hr before harvest (VLB-cells). 
mide on the 6th day of the immnn~z~ng  infection. The protective capacity of the lymphoid cells 
from these animals obtained a day later was compared with that of the cells from untreated 
donors. 
The  results  (Fig.  6)  showed  that  while  cells  from untreated  donors  were 
protective,  an  equal  number  of viable  cells  from  cyclophosphamide-treated 
animals were not. Thus, the immune lymphoid cells were sensitive to the cyto- 
toxic effect of cyclophosphamide. 
A similar experiment with vinblastine showed that treatment of donors with 
vinblastine 24 hr before harvesting of cells did not affect their functional ac- 
tivity in  recipients  (Fig.  8).  This  suggests  that  the  immune  lymphoid  cells o  °- 
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FIo. 8.  Growth curves of L. monocytogenes in: normal mice (control); recipients of immune 
spleen cells (cells);  and t~ecipients which had been treated with vinblastine 24 hr prior to trans- 
er of ~mmune spleen cells (cells -t- VLB T-24). 
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were in a resting phase and hence insensitive to the action of vinblastine which 
is a mitotic poison. 
Effect  of Irradiation  of Recipients  on  Passive  Immunization.--The  experi- 
ments on pretreatment of recipients with cyclophosphamide reported in the 
preceding section indicated that the host component required for the mediation 
of passive iramunlzation was insensitive to the action of this drug. Since cyclo- 
phosphamide is known to be toxic to the lymphoid series of cells (4)  and non- 
toxic  to  macrophages,  ~ it  was  reasonable  to  assume  that macrophages  and 
their precursors may be  the host components required for the mediation of 
passive immunization. The following experiments were undertaken to elucidate 
this question. 
A group of prospective recipients was exposed to 900 fads X-irradiation. Mter 24 hr they 
were injected  with specifically  immune  lymphoid  cells and challenged  with Li.steria; the course 
of the Listeria infection  is presented in Fig. 9 where it is compared with that found in unim- 
munized hosts and in passively  immunized  ~tn]mais  which  had not been irradiated. 
The  results  indicated  that  prior  irradiation  of  recipients  abolished  their 
capacity  to  benefit from  passive  immunization,  suggesting  that  protection 
depends upon the intervention of a radiosensitive cell supplied by the recipient. 
The growth curve shows, however, that partial protection existed for the first 
24 hr after transfer; thereafter, a steep, seemingly logarithmic rise occurred in 
the Listeria count. This suggests that the recipient was not able to sustain its 
contribution to the immune mechanism. The most plausible explanation is that 
the supply of phagocytic cells became exhausted. The studies of Volkman and 
Gowans (5, 6), and Volkman and Collln.q (7) have shown that blood monocytes 
arise from radiosensitive precursors in bone marrow. This cell type virtually 
disappears from circulation within 24 hr of irradiation. The tissue macrophage 
which derives from blood monocytes is thus the cell most likely to be missing 
from the defense mechanism of irradiated recipients. 
DISCUSSION 
Cytotoxic agents were employed in the present investigation with a  view to 
elucidating the cellular events which underlie the acquisition of  antimicrobial 
resistance  by  animals  which  have  been  passively  protected  with  immune 
lymphoid cells. Recipients were injected intravenously with 2 X  l0  s spleen cells 
obtained on day 7 of an immunizing infection with L. monocytogenes.  These 
were the conditions which had been found to provide optimal protection against 
Listeria  challenge (1).  Four drugs and X-irradiation, representing five broad 
categories of cytostatic agents, were studied. 
There is persuasive evidence that the primary immune response to Listeria 
t Mackaness, G. B., and S. P. Tripathy. 1959. The effect  of cytotoxic  agents on established 
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infection is generated through  the specific induction of cells belonging to the 
lymphoid series. Bacterial inactivation, however, is not accomplished by these 
cells; it is ultimately expressed nonspecifically through macrophages. Immunity 
in passively immunized animals  is also specific in induction, but is again mani- 
fested nonspecifically  through macrophages.  The latter conclusion is based upon 
the finding  that macrophages with nonspecific microbicidal properties and in- 
increased  spreading activity, characteristic features of activated macrophages, 
appear in the peritoneal cavity of recipients which have been protected with 
immune  lymphoid cells  and  challenged  simultaneously with  the homologous 
organism.  The donor cells which have this capacity to confer immunity on nor- 
mal recipients belong to the lymphoid series (1, 2). The exact sequence of events 
leading to the eventual activation of host macrophages following  transfer of 
donor immune lymphoid cells is not known; some information, however, is ob- 
tained from the results of the present study. 
Cyclophosphamide is known to be toxic to all cells belonging to the lymphoid 
series  (4); it does not,  however, affect the functional capacity of the macro- 
phage? Treatment of recipients with cyclophosphamide would therefore result 
in depletion of lymphoid tissue without impairment  of macrophage activity. 
The failure of pretreatment  of recipients with cyclophosphamide to interfere 
with the passive transfer of immunity (Fig.  6)  suggests  that participation  of 
recipient  lymphoid cells is not a  prerequisite  for the  activation  of recipient 
macrophages.  The total ablation of passive immunity with cyclophosphamide 
administered at the time of cell transfer is probably due, therefore,  to its direct 
lethal action on the donor lymphoid cells. This view is supported by the failure 
of what viable lymphoid spleen ceils could be obtained from cyclophosphamide- 
treated donors to confer protection upon normal recipients (Fig. 6). 
Vinblastine is a mitotic poison which selectively acts on cells entering mitosis, 
causing  metaphase arrest and subsequent death (8); its action is directly pro- 
portional to the level of cellular  proliferation  (9).  Injection of vinblastine to 
prospective donors on day 6 of an immunizing  infection  failed to affect the 
immunologic  capability of cells obtained on day 7; this observation, considered 
in  conjunction with  the finding  that  vinblastine failed  to influence  host re- 
sistance when injected on day 7 of a primary infection (3), suggests that sta- 
bilization of the immune cell population had occurred by this time, and that 
the  end-product  of  the  immune  response  (the  immunologicaUy  committed 
lymphoid cell) has entered a resting or intermitotic state by the 6th day of the 
immune response. 
In contrast to its inertness when given to donors, vinblastine administered to 
recipients  at the time of cell transfer completely suppressed the development of 
resistance.  This implies that the acquisition of resistance involves multiplication 
of donor lymphoid cells or recipient phagocytes, or possibly both cell types. 
In any case, vinblastine must cause the virtual elimination  of one of the compo- S. P. TRIPATHY  AND  G. B. MACKANESS  27 
nents  necessary  to  the  acquisition  of protective  immunity  in  passively ira. 
munized recipients.  The following  observations provide support for the con- 
tention that both donor lymphoid cells and recipient phagocytes do engage in 
multiplication as part of the host's defense mechanism. 
Earlier experiments (1) on the effect of mitomycin C indicate that this drug 
interferes to some extent with the immunologic  capability of donor lymphoid 
cells. It was found that immune cells which had been treated with this drug in 
vitro conferred  a  low but persisting  level of protection that  was unlike  the 
steeply mounting immunity found in recipients of untreated cells. Since mito- 
mycin C  at  a  low concentration is known to prevent multiplication  of cells 
without  impairment  of  protein  synthesis  (10),  it  would seem  that  optimal 
protection with immune lymphoid cells depends upon donor cell proliferation in 
the recipient (1). 
The fact that prior irradiation of recipients prevents them from acquiring  the 
resistance  normally  conferred  with  immune  lymphoid  cells  suggests  that  a 
radiosensitive  component  of  the  defense mechanism  is  contributed  by  the 
recipient itself.  Although macrophages are not directly affected by irradiation 
(11), recruitment of this cell type is known to require an intact mechanism for 
the production of circulating monocytes (5). The monocyte precursors in bone 
marrow are continuously dividing cells which are extremely radiosensitive (6). 
Since the normal monocyte has a life span in the circulation of only 1 day, ir- 
radiation results in a rapid depletion of circulating  monocytes (7). Hence, the 
present finding  that irradiated mice show some evidence of immunity during 
the first 24 hr after cell transfer but none thereafter, suggests that the recruit- 
ment of blood monocytes is essential to the defenses  of passively immlmlzed 
recipients. 
From the effect of mitomycin C on donor cells and of prior X-irradiation on 
recipients,  it is evident that protective immunity depends upon cellular  pro- 
liferation affecting  both donor cell  and host cell components of the defense. 
Vinblastine,  therefore,  could  exert  its  influence  through  both  of  these  cell 
populations.  The immediate immunosuppressive effect of vinblastine in pas- 
sively immunized an{reals, in contrast to what was seen following irradiation, 
suggests that its activity is largely due to its effect on the donor cells. 
In the present experiments,  methotrexate was only partially immunosuppres- 
sire in its effect on the passively immunized animal,  and was seen in the pre- 
vious paper to cause only transient suppression  of the immune response in ac- 
tively immunized animals (3). It is possible therefore that in both situations, a 
proportion of the immunologically committed lymphocytes may have escaped 
the thymidineless death produced with methotrexate (12, 13).  Apparently those 
which survive go on to provide a low level of protection for the recipient. 
The position is clearly different in the case of mitomycin C or vinblastine. 
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tein synthesis (10) so that the immunity conferred with mitomycin C-treated 
cells, as reported in another paper (1), presumably results from the activities 
of the cells transferred, unaided by any augmentation through cellular prolifera- 
tion.  This would explain  the low but persisting  level of protection conferred 
with cells which have been treated with this drug. This evidence argues  con- 
vincingly that donor lymphoid cells proliferate in recipients,  presumably as a 
result of specific antigenic stimulation.  The findings  with vinblastine tend to 
confirm  this view since this drug, when administered to recipients  at the time 
of cell transfer, totally abolished the protective capacity of the immune lymph- 
oid cells. 
The failure of azathioprine  to interfere with passive immunization suggests 
that it may not be active against immunologically  committed cells. It did, how- 
ever,  interfere with the development of immunity  during  a  primary Listeri~ 
infection (3), suggesting  that its immunosuppressive effect may be limited to a 
step in the inductive phase of the immune response,  as has been suggested in 
the case of a closely allied drug, 6-mercaptopurine (14). 
A feature of interest was the finding that the three drugs,  cyclophosphamide, 
vinblastine,  and methotrexate, which suppressed the passive  transfer of cellu- 
lar immunity, were also effective in suppressing  the primary immune response 
to Lisleria (3). It would thus seem that while drugs which suppress the passive 
transfer of immunity also suppress the primary response,  the converse may not 
be true, since azathioprine failed to influence resistance  in passively immunized 
mice.  Suppression  of resistance in passively immunized  animals  must  result 
therefore  from  a  direct  action  of drugs  on  the  immunologically  committed 
lymphoid cell. This view seems tenable since prior treatment of recipients with 
cyclophosphamide or vinblastine did not prevent the passive transfer of im- 
munity with immune lymphoid cells. 
No experiments have been performed as yet to study the vulnerability of 
the immunologicaUy committed cell to X-irradiation. It is possible, despite the 
radioresistance of an ongoing  antibody response,  that they would prove to be 
susceptible to ionizing irradiation in the system studied. It is even more likely 
that  X-irradiation  should  be  effective  in  suppressing  the  primary  immune 
response to Listeri~ through its destructive action on uncommitted lymphoid 
cells. That this is indeedso is suggested from the shapes of the growth curves in 
the irradiated  and unirradiated  controls (Fig.  9); while  an immune response 
was evident at 48 hr in the liver of normal mice,  bacterial counts were con- 
siderably higher in the irradiated  controls,  suggesting  an immunosuppression 
of the primary response  by X-irradiation. 
The findings in the present study indicate that the specific immunologically 
committed  lymphoid  cell  responsible  for  mediating  the  passive  transfer  of 
acquired  cellular  resistance  is  a  resting  cell which is  sensitive to  cyclophos- 
phamide,  is partially sensitive to methotrexate,  but is insensitive  to azathio- 
prine,  and also to vinblastine while it remains in the resting state. S.  P.  TRIPATHY AND  G.  B.  MACKANESS  29 
SUMMARy 
A  system involving the passive transfer of committed lymphoid cells from 
Lis~ria-imrnune  donors has  been used  to  study  the  phases  of  the  {mmune 
response which are sensitive to the immunosuppressive action of various cyto- 
toxic agents. The agents investigated included cyclophosphamide, vinblastine, 
methotrexate, azathioprine, and X-irradiation. 
Complete suppression of passive immunization was obtained by the admin- 
istration of cyclophosphamide or vinblastine to recipients at the time of cell 
transfer  or  by  prior  X-irradiation  of  recipients  a  day  before  cell transfer. 
Methotrexate  was  only partially  suppressive,  whereas  azathioprine  had  no 
effect at all.  The donor cell responsible for the transfer of immunity to recip- 
ients was shown to be a  resting cell which is sensitive to the action of cyclo- 
phosphamide but not to vinblastine. 
The results of this investigation suggest that the donor cells undergo multi- 
plication  in  the  tissues  of  the  recipient,  presumably in  response  to  specific 
stimulation by L~teria antigens. This in turn results in the activation of host 
macrophages. The immunosuppressive action of cyclophosphamide, vinblastine, 
and irradiation in the cell-transfer system has been discussed in relation to a 
direct cytotoxic action on the immune lymphoid cells of the donor and specific 
interference with their proliferation in the recipient, as well as impairment of 
macrophage production on the part of the recipient itself. 
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